The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with ...

The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

The indications for ViV‐TAVR were determined by a multidisciplinary heart team at the Cedars‐Sinai Medical Center. The decision on the appropriate device and access site for each procedure was based ...

[Image courtesy of Plexāā] Plexāā recently announced a new partnership with Panasonic Manufacturing UK as their contract manufacturer for the Bloom device. The company says the Bloom platform ...

The Transcatheter Aortic Valve Replacement Market primarily revolves around devices designed for minimally invasive valve replacement procedures, which are increasingly preferred over traditional open ...

Edwards Lifesciences (NYSE:EW) reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This ...

Edwards Lifesciences reported better-than-expected fourth-quarter sales, driven by its transcatheter aortic valve replacement (TAVR) devices, to finish 2024 on an upbeat but cautious note after a ...